We create new treatments
based on cutting-edge approaches.
We create new treatments
based on cutting-edge approaches.
We create new treatments
based on cutting-edge approaches.
We create new treatments
based on cutting-edge approaches.
At PimedBio, we’ve developed a cutting-edge platform technology called "Drugging Informatics™", designed to discover innovative drug candidates that can effectively manage the complex signaling pathways involved in challenging diseases like cancer and immune-mediated inflammatory diseases (IMIDs).
"Drugging Informatics™" is an advanced informatics approach that leverages big data to uncover new drug targets driving multiple disease-related pathways according to disease contexts, and design therapies to inhibit these target. This platform is especially tailored for treating diseases with complex origins, where traditional treatments often fall short.
"Drugging Informatics™" offers an integrative approach to managing diseases that involve complex and varied signaling pathways. By targeting the root causes of these pathways, our technology enables the creation of drug candidates that can effectively treat diseases that have been difficult to manage with conventional therapies.
Through this innovative platform, PimedBio is leading the way in developing next-generation therapies that promise to make a significant impact on the treatment of intractable diseases.